1 Introduction
Forward-lookingstatements
This Annual Report and the Consolidated Financial Statements contain "forward-looking statements" as defined under U.S. federal securities laws. Forward-looking statements are based on our current expectations of future events and many of these statements can be identified using terminology such as "believes," "expects," "anticipates," "plans," "may," "will," "projects," "continues," "estimates," "potential," "opportunity" and similar expressions. These forward-looking statements, which include, but are not limited to, statements related to the COVID-19 coronavirus pandemic, our collaboration and license agreement with CSL Behring LLC and the timing of the completion of the transactions contemplated thereby, our beliefs about competitive advantage and the capabilities of our manufacturing facility, our cash runway, the advancement of clinical trials, our intellectual property portfolio, and the impact of regulatory actions on our regulatory submission timelines, may be found in Part II, Part III, Part IV and other sections of this Annual Report.